Equities

Simris Group AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Simris Group AB

Actions
  • Price (SEK)0.1605
  • Today's Change-0.012 / -6.69%
  • Shares traded744.79k
  • 1 Year change+88.38%
  • Beta0.3607
Data delayed at least 15 minutes, as of Feb 10 2026 13:35 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Simris Group AB is a Sweden-based company primarily engaged in the special foods and wellbeing products industry. The Company operates as a manufacturer of dietary supplements as well as specialty foods. The Company's products are based on algae-plants that live in water, such as strains of cyanobacteria. These products are rich of Omega-3 oils produced by microalgae on dry land and made from natural ingredients. The Company scope of activity includes development of technologies and processes for cultivation and production with microalgae, consulting and marketing in manufacturing, technology as well as environmental services with microalgae. The Company's technology provides access to bioactive substances while replacing unsustainable raw materials from endangered marine species and ecosystems.

  • Revenue in SEK (TTM)2.30m
  • Net income in SEK-29.23m
  • Incorporated2011
  • Employees6.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lohilo Foods AB (publ)191.97m-2.56m56.50m22.00--4.6345.020.2943-0.068-0.0685.100.32412.668.3317.628,346,522.00-3.55-29.86-14.08-74.3032.6530.61-1.34-13.430.27540.10610.5753--12.657.7092.18------
New Nordic Healthbrands AB575.39m8.08m104.39m77.0012.921.029.520.18141.301.3092.8816.542.321.936.087,991,570.003.261.947.883.9864.2966.251.400.88110.82515.190.275376.223.083.99-24.30--21.35--
Simris Group AB2.30m-29.23m201.60m6.00------87.61-0.0638-0.06380.0046-0.02280.01511.162.43287,625.00-19.20-26.85-23.51-30.6169.97-11.89-1,270.27-765.740.1508-32.84-----33.6210.647.24--11.48--
Fodelia Oyj-1.06tn-1.06tn441.87m131.00--------------------------1.78--2.76--46.93--0.9629------121.991.7318.86310.192.75-23.29--
Hofseth Biocare ASA232.11m-121.40m496.86m65.00------2.14-0.3172-0.31720.6064-0.06610.65862.259.80---34.45-30.01-70.77-50.0538.1324.22-52.30-81.950.4723-9.021.11--32.0930.59-17.45---27.30--
Skane mollan AB236.40m11.10m607.20m27.0054.703.8433.552.571.011.0121.4914.391.24--10.938,755,556.005.818.846.469.9616.5018.844.706.73------90.85-10.813.62-31.41-11.37--3.13
Premium Snacks Nordic AB529.65m21.70m677.36m70.0031.068.2920.441.281.601.6039.456.012.787.2611.437,566,357.0011.381.0122.621.9541.2340.654.100.44170.653613.150.335133.6122.437.43938.6455.64-3.02--
Apetit Oyj1.77bn58.47m940.19m310.0015.890.85527.080.53150.8810.88126.7616.371.363.5626.00453,406.004.513.845.125.2834.6223.553.312.451.188.330.067867.94-7.35-11.35-12.37---5.0310.76
Data as of Feb 10 2026. Currency figures normalised to Simris Group AB's reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.